Our results demonstrate that also in immortalized MEF miR-28 targets ASF/SF2 suggesting that its tumor suppressor activity is due to ASF/SF2 inhibition, although other targets cannot be excluded. The gene discussed is SRSF1; the disease is neoplasm.